Krystal Biotech vs its peers
The 10 largest Biotechnology companies by market value, prices of Nov 20, 2026
Krystal Biotech is the 10th largest of the 10 biggest Biotechnology companies on OQRO by market value, at $9.15B. Its revenue of $389M in fiscal 2025 ranks 10th of 10. It keeps 41% of revenue as operating profit, 2nd of 9 (median 34%). Revenue grew 34% on the year before, against a median of +8.0%. At 44.7x its latest annual earnings, the market prices it above its peers (median 22.6x).
Side by side
| Company | Market value | Revenue | Growth y/y | 5-yr growth / yr | Gross margin | Operating margin | Net margin | Free cash flow margin | R&D / revenue | Price / earnings | Price / sales | FCF yield | Stock, 12 months |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AmgenAMGN · FY2025 | $236B | $36.8B | +10.0% | +7.6% | 67.2% | 24.7% | 21.0% | 22.0% | 19.8% | 30.6x | 6.4x | 3.4% |
Each company’s latest fiscal year (FY), so the years can end a few months apart. Price ratios divide today’s market value by that year’s figure; price / earnings is left out on a loss. “—” means the company did not tag that line in its annual report.
Operating margin
- UTHR47%
- KRYS41%
- EXEL38%
- VRTX35%
- GILD34%
- INCY29%
- REGN25%
- AMGN25%
- MRNA−158%
Compare Krystal Biotech head to head
Where Krystal Biotech’s revenue comes from and where it goes: Krystal Biotech revenue breakdown. Twenty years of results: Krystal Biotech financial history.
Common questions
Who are Krystal Biotech's competitors?
The largest companies in its industry (Biotechnology) by market value: Amgen (AMGN), Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Moderna (MRNA), Biogen (BIIB), United Therapeutics (UTHR), Incyte (INCY) and Exelixis (EXEL). They share Krystal Biotech's industry listing; not every one competes with it on every product.
Is Krystal Biotech bigger than Amgen?
No, by market value: Krystal Biotech is worth $9.15B and Amgen $236B. By revenue, Krystal Biotech brought in $389M in fiscal 2025 and Amgen $36.8B in fiscal 2025.
How does Krystal Biotech's valuation compare with its peers?
Where these figures come from
The group is the companies OQRO lists in the same industry as Krystal Biotech (Biotechnology), the largest 9 by market value, plus Krystal Biotech. Companies whose latest annual report is more than a year and a half old, or that report in a currency other than the dollar, are left out.
Revenue, operating income, net income, gross profit, research and development and free cash flow (cash from operations minus capital expenditure) are each company’s own full-year lines from its latest 10-K, as tagged in XBRL (SEC companyfacts). Market value is the last close times the shares outstanding on the latest filing. Price / earnings is market value over net income; price / sales is market value over revenue; free cash flow yield is free cash flow over market value. Five-year growth is the yearly rate that takes revenue from five fiscal years before to the latest. This page describes the past and is not investment advice. No language model wrote it.









